Overview
- 3 FDA inspections are on record.
- 3 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-11-01.
At a glance
Inspections
3
Form 483s
3
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 27 Oct 2025 – 1 Nov 2025 | Human Drugs | 483 | View 483 → |
| 23 Jan 2023 – 27 Jan 2023 | Human Drugs | 483 | On file |
| 1 Jun 2022 – 7 Jun 2022 | Human Drugs | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
1 Nov 2025
21 CFR 211.22(a)
Authority lacking to review records, investigate errors
Cited by Rafeeq A Habeeb
1 Nov 2025
21 CFR 211.42(a)
Buildings of Suitable Size, Construction, Location
Cited by Rafeeq A Habeeb
Investigators
FDA investigators tied to this site in the record.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(8) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Naari Pharma Private Limited's 3 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat